154 related articles for article (PubMed ID: 15116125)
1. Use of recombinant factor VIIa in infants with severe coagulopathy.
Fontaine MJ; Lazarchick J; Taylor S; Annibale D
J Perinatol; 2004 May; 24(5):310-1. PubMed ID: 15116125
[TBL] [Abstract][Full Text] [Related]
2. The use of recombinant activated factor VII to control bleeding in a preterm infant undergoing exploratory laparotomy.
Chuansumrit A; Nuntnarumit P; Okascharoen C; Teeraratkul S; Suwansingh S; Supapannachart S
Pediatrics; 2002 Jul; 110(1 Pt 1):169-71. PubMed ID: 12093965
[TBL] [Abstract][Full Text] [Related]
3. Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy.
Shami VM; Caldwell SH; Hespenheide EE; Arseneau KO; Bickston SJ; Macik BG
Liver Transpl; 2003 Feb; 9(2):138-43. PubMed ID: 12548507
[TBL] [Abstract][Full Text] [Related]
4. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage.
Brady KM; Easley RB; Tobias JD
Paediatr Anaesth; 2006 Oct; 16(10):1042-6. PubMed ID: 16972833
[TBL] [Abstract][Full Text] [Related]
5. Use of recombinant factor VIIa in a preterm infant with coagulopathy and subdural hematoma.
Altuncu E; Berrak S; Bilgen H; Yurdakul Z; Canpolat C; Ozek E
J Matern Fetal Neonatal Med; 2007 Aug; 20(8):627-9. PubMed ID: 17674281
[TBL] [Abstract][Full Text] [Related]
6. Recombinant activated factor VII for cerebral injury-induced coagulopathy in pediatric patients. Report of three cases and review of the literature.
Morenski JD; Tobias JD; Jimenez DF
J Neurosurg; 2003 Mar; 98(3):611-6. PubMed ID: 12650436
[TBL] [Abstract][Full Text] [Related]
7. Recombinant factor VIIa in paediatric bleeding disorders--a 2006 review.
Mathew P; Young G
Haemophilia; 2006 Sep; 12(5):457-72. PubMed ID: 16919075
[TBL] [Abstract][Full Text] [Related]
8. Recombinant activated factor VIIa use in massive transfusion and coagulopathy unresponsive to conventional therapy.
Gowers CJ; Parr MJ
Anaesth Intensive Care; 2005 Apr; 33(2):196-200. PubMed ID: 15960401
[TBL] [Abstract][Full Text] [Related]
9. Recombinant factor VIIa improves coagulopathy caused by liver failure.
Brown JB; Emerick KM; Brown DL; Whitington PF; Alonso EM
J Pediatr Gastroenterol Nutr; 2003 Sep; 37(3):268-72. PubMed ID: 12960648
[TBL] [Abstract][Full Text] [Related]
10. Recombinant activated factor seven in acute life-threatening bleeding in neonates: report on three cases and review of literature.
Hünseler C; Kribs A; Eifinger F; Roth B
J Perinatol; 2006 Nov; 26(11):706-13. PubMed ID: 17066067
[TBL] [Abstract][Full Text] [Related]
11. Novel applications of recombinant factor VIIa for the management of pediatric coagulopathic diseases.
Mathew P; Winter SS; Frost JD; Hanrahan J; Schwartz M; Jones JE
J Pediatr Hematol Oncol; 2003 Jun; 25(6):499-502. PubMed ID: 12794532
[TBL] [Abstract][Full Text] [Related]
12. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
Brenner B; Wiis J
Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
[TBL] [Abstract][Full Text] [Related]
13. Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profile.
Levy JH; Fingerhut A; Brott T; Langbakke IH; Erhardtsen E; Porte RJ
Transfusion; 2006 Jun; 46(6):919-33. PubMed ID: 16734808
[TBL] [Abstract][Full Text] [Related]
14. A novel hemostatic agent: the potential role of recombinant activated factor VII (rFVIIa) in anesthetic practice.
Murkin JM
Can J Anaesth; 2002 Dec; 49(10):S21-6. PubMed ID: 12546007
[TBL] [Abstract][Full Text] [Related]
15. Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases.
Mitsiakos G; Papaioannou G; Giougi E; Karagianni P; Garipidou V; Nikolaidis N
J Pediatr Hematol Oncol; 2007 Mar; 29(3):145-50. PubMed ID: 17356391
[TBL] [Abstract][Full Text] [Related]
16. Recombinant factor VIIa in the treatment of bleeding.
Midathada MV; Mehta P; Waner M; Fink LM
Am J Clin Pathol; 2004 Jan; 121(1):124-37. PubMed ID: 14750250
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of the recombinant factor VIIa in patients with the coagulopathy of advanced child's B and C cirrhosis.
Bernstein D
Semin Thromb Hemost; 2000; 26(4):437-8. PubMed ID: 11092221
[TBL] [Abstract][Full Text] [Related]
18. "Off-license" use of recombinant activated factor VII.
Ghorashian S; Hunt BJ
Blood Rev; 2004 Dec; 18(4):245-59. PubMed ID: 15501553
[TBL] [Abstract][Full Text] [Related]
19. Recombinant-activated coagulation factor VIIa (NovoSeven): current development.
Weiskopf RB
Vox Sang; 2007 May; 92(4):281-8. PubMed ID: 17456151
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous liver hemorrhage during laparotomy for necrotizing enterocolitis: a potential role for recombinant factor VIIa.
Filan PM; Mills JF; Clarnette TD; Ekert H; Ekert P
J Pediatr; 2005 Dec; 147(6):857-9. PubMed ID: 16356448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
